Psoriasis

(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has approved a new plaque psoriasis drug. This new medication is found under the brand name Sotyktu. Its active ingredient is deucravacitinib. This drug is approved to treat adults with moderate to severe plaque psoriasis who will likely benefit from injection, pills or ultraviolet treatment. …

FDA approves Sotyktu (deucravacitinib) to treat plaque psoriasis | Carrick Pharmacy Read More »